Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.20 (
alpha-glucosidase
)
4,237
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. Trehalase, sucrase-isomaltase and
maltase-glucoamylase
are three integral glycoproteins of the brush border membranes of the enterocytes. On the basis of a comparative study on alpha-glycosidase activities (sucrase, isomaltase,
maltase
,
glucoamylase
and trehalase) associated to these glycoproteins during neonatal development, mammals could be basically divided into three groups. 2. In rodents and rabbit alpha-glycosidase activities are low or undetectable during the suckling period and increase to adult levels during the weaning period. In cat, dog and the primates examined, alpha-glycosidase activities are well or fully developed at birth. 3. In ruminants and pinnipedia alpha-glycosidases are low or absent throughout life. 4. During the suckling period of rat, mouse and rabbit, glucocorticoids trigger a premature and dramatic increase of all alpha-glycosidases. 5. On the contrary, alpha-glycosidases development during the weaning period appears to be independent of glucocorticoids. Neither hypophysectomy nor adrenalectomy prevent the development of alpha-glycosidases; only the rate of increase is reduced. 6. Transplantations of intestinal isografts either in adult or suckling animal, have shown that (1) no systemic factor inhibits the expression of alpha-glycosidase, (2) alpha-glycosidases induction is neither triggered by luminal alimentary substances, nor by hormones, (3) alpha-glycosidase development is controlled by an intrinsic ontogenic program. 7. The use of an antiglucocorticoid failed to inhibit the spontaneous development of alpha-glycosidase activities. 8. The increase of
maltase
and sucrase activities triggered by glucocorticoids is associated with an increase of the concentration of two glycoproteins in the microvillous membrane: sucrase-isomaltase and
maltase-glucoamylase
. 9. After administration of glucocorticoids the increase of
maltase
, sucrase and trehalase is strongly inhibited by actinomycin-D and the increase of sucrase activity is associated with a parallel increase of sucrase-isomaltase mRNA. Transcription is most likely the primary site of control of alpha-glycosidase biosynthesis. 10. In the crypt cells, alpha-glycosidases biosynthesis appears to be triggered by a receptor-mediated glucocorticoid interaction. 11. The enterocytes synthesize more alpha-glycosidase molecules as they travel to the tip of the villi. 12. The simultaneous, biosynthesis of sucrase-isomaltase and
maltase-glucoamylase
triggered by glucocorticoids, as well as their simultaneous normal development suggest that they may be subjected to related control mechanisms. 13. It is suggested that sucrase-isomaltase and
maltase-glucoamylase
might have arisen by several cycles of partial gene duplication of an ancestor gene coding for a single site
maltase
-isomaltase; subsequent mutation would have transformed isomaltase into sucrase or
glucoamylase
.
...
PMID:Brush border membrane sucrase-isomaltase, maltase-glucoamylase and trehalase in mammals. Comparative development, effects of glucocorticoids, molecular mechanisms, and phylogenetic implications. 251 62
Starch-degrading, amylolytic enzymes are widely distributed among microbes. Several activities are required to hydrolyze starch to its glucose units. These enzymes include alpha-amylase, beta-amylase,
glucoamylase
,
alpha-glucosidase
, pullulan-degrading enzymes, exoacting enzymes yielding alpha-type endproducts, and cyclodextrin glycosyltransferase. Properties of these enzymes vary and are somewhat linked to the environmental circumstances of the producing organisms. Features of the enzymes, their action patterns, physicochemical properties, occurrence, genetics, and results obtained from cloning of the genes are described. Among all the amylolytic enzymes, the genetics of alpha-amylase in Bacillus subtilis are best known. Alpha-Amylase production in B. subtilis is regulated by several genetic elements, many of which have synergistic effects. Genes encoding enzymes from all the amylolytic enzyme groups dealt with here have been cloned, and the sequences have been found to contain some highly conserved regions thought to be essential for their action and/or structure. Glucoamylase appears usually in several forms, which seem to be the results of a variety of mechanisms, including heterogeneous glycosylation, limited proteolysis, multiple modes of mRNA splicing, and the presence of several structural genes.
...
PMID:Microbial amylolytic enzymes. 254 11
Maturation of mechanisms for carbohydrate absorption occurs in a defined sequence during human fetal development. The intestinal enzymes, lactase, sucrase,
maltase
, isomaltase, and
glucoamylase
, are at mature levels in the term fetus. Mature levels of pancreatic amylase activity and glucose transport occur postnatally, and levels are low in both the term and preterm neonate. In the preterm infant, sucrase,
maltase
, and isomaltase are usually fully active, but lactase activity, which increases markedly from 24 to 40 weeks, may be low depending upon fetal age. Despite these developmental patterns, clinical lactose intolerance is uncommon. Postnatal adaptive responses to ingested carbohydrates lead to competent carbohydrate absorption. Inadequately absorbed carbohydrates are salvaged by colonic flora through fermentation of carbohydrates to hydrogen gas and short-chain fatty acids; the latter are readily absorbed by the colon. In this setting, carbohydrate tends to be absent from the stool. Noninvasive reflection of the status of carbohydrate absorption may be obtained from breath hydrogen testing, a technique of particular value in young infants.
...
PMID:Development of carbohydrate absorption in the fetus and neonate. 257 23
By means of biochemical determination of the activity of hydrolases in the digestive system, studies have been made on the enzymic spectrum in the pancreas and small intestine in postnatal life of astrakhan sheep. It was shown that to the moment of birth, animals possess the developed mechanisms of the initial and final stages of hydrolysis of proteins and lipids. At this period, carbohydrate hydrolysis system is presented only by lactase, the activity of pancreatic alpha-amylase, intestinal
gamma-amylase
and
maltase
being very low, whereas the activity of saccharides is absent at all. During further development of sheep, the activity of all digestive hydrolases gradually increases, except that of lactase which is almost absent in adult specimens. Saccharides activity was not find in the mucose of the small intestine within the whole postnatal life.
...
PMID:[The enzyme systems of the cavitary and membrane hydrolysis of foodstuffs in the ontogeny of Karakul sheep]. 259 5
We describe a new and unique gastric carcinoma cell line (LIM1839) derived from a young Caucasian male with rapidly progressing disease. The cell line grows with a pleomorphic morphology and has been in continuous culture for more than 3 years. The cells cannot be cloned in semi-solid agar or grown in nude mice despite numerous attempts. The karyotype of the cultured cells is highly abnormal with a large number of structural and numerical changes. Some chromosomes are dicentric and this feature has persisted in this culture. The cells express one of the small-intestinal dipeptidases, aminopeptidase N, but do not express dipeptidyl peptidase IV or the disaccharidases, sucrase isomaltase or
maltase
glucoamylase
. The cells express high levels of EGF receptors and of messenger RNA for insulin-like growth factor II.
...
PMID:A new gastric carcinoma cell line (LIM1839) derived from a young Caucasian male. 260 77
Pompe's disease is characterised by an absence of
lysosomal alpha-glucosidase
, but this enzyme is also inhibited by Castanospermum australe seeds. Four calves were fed C. australe seeds at the rate of 0.15 g/kg body weight for periods from 1 to 4 days. Lymphocyte
alpha-glucosidase
activity was reduced by at least 90%, with the majority of inhibition occurring within 8 h of dosing. Several weeks elapsed before activity returned to normal. Significant inhibition of muscle
alpha-glucosidase
occurred and the ratio of plasma
alpha-glucosidase
activity measured at pH 5.6 relative to that at pH 3.7 was depressed. In an attempt to induce Pompe's disease, 2 calves were dosed with 1.2 g C. australe seed/kg body weight/day for 13 months. Lymphocyte and muscle
alpha-glucosidase
activities were markedly reduced over the entire period of feeding, but the animals showed no clinical signs of disease. Tissue cells were not vacuolated nor did they show any apparent accumulation of glycogen. Despite significant inhibition of
alpha-glucosidase
in skeletal and cardiac muscle, liver, kidney and brain, it is suggested that there was sufficient residual enzyme to prevent induction of a phenocopy of Pompe's disease.
...
PMID:Inhibition of alpha-glucosidase in cattle by Castanospermum australe: an attempted phenocopy of Pompe's disease. 265 94
Simultaneous azo-coupling and indigogenic methods were evaluated for the quantitative histochemical assay of the plasma membrane proteases gamma-glutamyl transpeptidase (EC 2.3.2.2) and dipeptidyl peptidase IV (EC 3.4.14.5) and the glycosidases
maltase-glucoamylase
and
glucoamylase
(
EC 3.2.1.20
) in decidual cells, jejunal enterocytes and renal proximal tubulocytes. Using kinetic (continuous) microdensitometry, a linear increase in the final reaction product was found from 3 up to 10 min, depending on the substrate concentration and the plasma membrane glycosidase or protease under investigation. Combined continuous and end point (static) microdensitometry revealed a linear relationship between the section thickness (enzyme concentration) and final reaction product up to 12 microns for the proteases and up to 16 microns for the glycosidases. Apparent Km and Vmax values were calculated with a computerized version of the direct linear plot and compared with the results obtained with the linear transformations according to Lineweaver-Burk, Eadie-Hofstee and Hanes. Apparent Km and Vmax values for the proteases were calculated separately for each animal and were 1.82 mM and 1.02 mM and 2.43 arbitrary units (a.u.) and 1.67 a.u. (gamma-glutamyl transpeptidase, decidua) and 0.42 mM and 0.38 mM and 0.29 and 0.26 a.u. (dipeptidyl peptidase IV, decidua). For the alpha-D-glucosidases, the corresponding values were 0.23 mM and 0.15 a.u. (kidney) and 0.55 mM and 0.20 a.u. (jejunum). The results show the suitability of the indigogenic methods for quantitative histochemical measurements of plasma membrane alpha-D-glucosidases, whereas the simultaneous azo-coupling procedures seemed to be less suitable for the quantification of surface membrane proteases, due to, for example, interactions of diazonium salts with amino acid or peptide substrates, reaction products and peptide activators.
...
PMID:Reaction rate measurements of proteases and glycosidases with chromogenic methods. 268 13
The lysosomal storage disorder glycogenosis type II, caused by a deficiency of
lysosomal alpha-glucosidase
, is very heterogeneous in its clinical presentation. It has been suggested that this heterogeneity may be due to differential expression of neutral alpha-glucosidases. We have therefore analysed the activity of the major neutral alpha-glucosidases in cultured fibroblasts or muscle cells from 26 patients with glycogenosis type II. The results indicate that there is no correlation between the expression of neutral
alpha-glucosidase
isoenzymes and the clinical phenotype of this disease.
...
PMID:An investigation of the possible influence of neutral alpha-glucosidases on the clinical heterogeneity of glycogenosis type II. 268 40
We have shown previously (R.P.J. Oude Elferink, E.M. Brouwer-Kelder, I. Surya, A. Strijland, M. Kroos, A.J.J. Reuser, J.M. Tager, Eur. J. Biochem. 139, 489-495 (1984)) that human urine contains considerable amounts of a precursor form of
lysosomal alpha-glucosidase
(about 50% of the total
alpha-glucosidase
activity present). We have now purified
alpha-glucosidase
from human kidney. Only about 5 to 10% of the total
lysosomal alpha-glucosidase
present in kidney comprises the precursor form of the enzyme. By means of immunocytochemistry using monoclonal antibodies, the precursor of
alpha-glucosidase
was detected in the brush border of the proximal tubule cells. Taking into account the amount of precursor
alpha-glucosidase
excreted daily into the urine and the amount present in the kidneys, we conclude that extensive secretion of precursor
alpha-glucosidase
occurs from the brush border of the proximal tubules.
...
PMID:Secretion of a precursor form of lysosomal alpha-glucosidase from the brush border of human kidney proximal tubule cells. 269 57
Enhancement of human NK cytotoxicity in the presence of fresh Viscum album extract and some commercial V. album extracts Iscador correlated strictly with an increased formation of lytic effector cell/K562 tumor cell conjugates in the single-cell assay. Both activities were completely destroyed by pretreatment of V. album extracts with pectinase, hemicellulase,
amyloglucosidase
and
alpha-glucosidase
, but not with proteases and RNase, i.e., the activities are linked to a polysaccharide. The active component in V. album extract was non-dialysable at a molecular weight cutoff of 10,000. Inhibition of both activities was observed with D-galacturonic acid, poly-galacturonic acid and pectins. The site of galacturonic acid-specific interaction could be identified on the effector cells. The rate of effector cell/tumor cell conjugate formation in the presence of V. album extracts, as well as the abrogation of both activities by pretreatment of V. album extracts with exoglycosidases specific for sugars other than galacturonic acid indicated an action of the NK cytotoxicity-enhancing component on the basis of a bridging mechanism. However, no conclusive results could be obtained for the structural specificity of the site interacting with the target cells.
...
PMID:Biochemical characterization of a component in extracts of Viscum album enhancing human NK cytotoxicity. 270 32
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>